Biblio
Export 1170 results:
Author [ Title] Type Year Filters: First Letter Of Last Name is R [Clear All Filters]
“Alcohol Intake and Cognitively Healthy Longevity in Community-Dwelling Adults: The Rancho Bernardo Study.”, J Alzheimers Dis, vol. 59, no. 3, pp. 803-814, 2017.
, “Algoplus® Scale in Older Patients with Dementia: A Reliable Real-World Pain Assessment Tool.”, J Alzheimers Dis, vol. 56, no. 2, pp. 519-527, 2017.
, “Allocentric and Egocentric Spatial Processing in Middle-Aged Adults at High Risk of Late-Onset Alzheimer's Disease: The PREVENT Dementia Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 885-896, 2018.
, “Allocentric and Egocentric Spatial Processing in Middle-Aged Adults at High Risk of Late-Onset Alzheimer's Disease: The PREVENT Dementia Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 885-896, 2018.
, “Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1103-1114, 2022.
, “Alterations in Synaptic Connectivity and Synaptic Transmission in Alzheimer's Disease with High Physical Activity.”, J Alzheimers Dis, vol. 99, no. 3, pp. 1005-1022, 2024.
, “Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 2, pp. 615-631, 2017.
, “Alterations of Effective Connectivity Patterns in Mild Cognitive Impairment: An MEG Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 843-854, 2018.
, “Altered Affective Evaluations of Smells in Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 433-41, 2016.
, “Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model.”, J Alzheimers Dis, vol. 56, no. 2, pp. 775-788, 2017.
, “Altered microRNA, mRNA, and Protein Expression of Neurodegeneration-Related Biomarkers and Their Transcriptional and Epigenetic Modifiers in a Human Tau Transgenic Mouse Model in Response to Developmental Lead Exposure.”, J Alzheimers Dis, vol. 63, no. 1, pp. 273-282, 2018.
, “Altered sense of humor in dementia.”, J Alzheimers Dis, vol. 49, no. 1, pp. 111-9, 2016.
, “Altered Sphingolipid Balance in Capillary Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 60, no. 3, pp. 795-807, 2017.
, “Alzheimer's Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1495-1506, 2018.
, “Alzheimer's and Parkinson's Diseases and the Risk of Cancer: A Cohort Study.”, J Alzheimers Dis, vol. 72, no. 4, pp. 1269-1277, 2019.
, “Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.”, J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
, “Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.”, J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
, “Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.”, J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
, “Alzheimer's Disease Biomarkers Have Distinct Associations with Specific Hippocampal Subfield Volumes.”, J Alzheimers Dis, vol. 66, no. 2, pp. 811-823, 2018.
, “Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches.”, J Alzheimers Dis, vol. 57, no. 3, pp. 683-696, 2017.
, “Alzheimer's Disease Computer-Aided Diagnosis: Histogram-Based Analysis of Regional MRI Volumes for Feature Selection and Classification.”, J Alzheimers Dis, vol. 65, no. 3, pp. 819-842, 2018.
, “Alzheimer's Disease Computer-Aided Diagnosis: Histogram-Based Analysis of Regional MRI Volumes for Feature Selection and Classification.”, J Alzheimers Dis, vol. 65, no. 3, pp. 819-842, 2018.
, “Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.”, J Alzheimers Dis, vol. 48, no. 1, pp. 175-87, 2015.
, “Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.”, J Alzheimers Dis, vol. 48, no. 1, pp. 175-87, 2015.
, “Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.”, J Alzheimers Dis, vol. 48, no. 1, pp. 175-87, 2015.
,